FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to immunology, and can be used for prevention and/or therapy of immune disease associated with BTK. Agent for preventing and/or treating an immune disease associated with BTK contains as an active ingredient a compound of general formula (I). Group of inventions also relates to use of said agent for treating immune disease, which is atopic dermatitis, rheumatoid arthritis, systemic lupus erythematosus, allergic rhinitis or pollinosis.
EFFECT: said agent has high selectivity of inhibiting BTK (Bruton tyrosine kinase) compared to EGFR, which enables to use it for treating immune diseases associated with BTK.
44 cl, 5 dwg, 25 tbl, 61 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF | 2014 |
|
RU2666349C2 |
| COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
| NOVEL PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2705579C2 |
| FGFR AND ITS MUTATION INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2811207C1 |
| ANTITUMOR EFFECT STRENGTHENING AGENT USING PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND | 2018 |
|
RU2799006C2 |
| PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2124016C1 |
| CARBOXAMIDE COMPOUNDS AND USING THEM AS CALPAIN INHIBITORS | 2010 |
|
RU2540856C2 |
| AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR | 2017 |
|
RU2764523C2 |
| 3,5-DISUBSTITUTED ALKYNYLBENZENE COMPOUND AND SALT THEREOF | 2013 |
|
RU2576384C1 |
| SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS | 2011 |
|
RU2603637C2 |
